Identification of Factors Associated With Physical Activity Levels in Adult Muscle Diseases
29 de julio de 2020 actualizado por: Fatma Ayvat, Hacettepe University
Erişkin Kas hastalıklarında Fiziksel Aktivite Ile ilişkili faktörlerin Belirlenmesi
To evaluate physical activity levels and factors associated with physical activity levels in adult patients with muscle diseases.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
The same protocol will be applied all of the patients and healthy subjects.
Individuals will be informed in detail about the study and demographic and physical properties will recorded after receiving approval.
Evaluation programme that consisting of pain, fatigue, falls, activity limitations, quality of life, muscle strength assessment and functional assessment will be applied.
After the evaluation, individuals will be given detailed information on the use of SenseWear activity monitors.
Individuals will wear SenseWear activity monitors on right triceps muscle for 5 days.
The data stored on the device will be recorded in computer using the software.
Individuals will be given information of the resulting data (total number of steps, total energy expenditure, the number of daily steps and energy expenditure, physical activity duration in different intensity).
Physical activity levels will be assessed by subjective aspects of physical activity questionnaire.
Tipo de estudio
Intervencionista
Inscripción (Actual)
80
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Ankara, Pavo, 06100
- Hacettepe University, Faculty of Health Sciences
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
20 años a 40 años (Adulto)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Clinical diagnosis of muscle diseases
- Adult patients with muscle diseases who are able to walk independently
Exclusion Criteria:
- Clinical diagnosis of systemic problems
- Any orthopedic problems that will affect the performance of the physical activity
- Clinical diagnosis of neurological disease other than muscle disease
- Clinical diagnosis of cognitive impairment
- Individuals who underwent surgery in the last 6 month
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Muscle Disease Group
Adult patients with muscle diseases diagnosed by neurologist, will wear SenseWear activity monitor for 5 days
|
Individuals will wear SenseWear activity monitors on right triceps muscle for 5 days.
The data stored on the device will be recorded in computer using the software.
Individuals will be given information of the resulting data (total number of steps, total energy expenditure, the number of daily steps and energy expenditure, physical activity duration in different intensity).
|
|
Comparador activo: Healthy Individuals Group
Healthy individuals with similar demographic characteristics as adult patients with muscle diseases, will wear SenseWear activity monitor for 5 days
|
Individuals will wear SenseWear activity monitors on right triceps muscle for 5 days.
The data stored on the device will be recorded in computer using the software.
Individuals will be given information of the resulting data (total number of steps, total energy expenditure, the number of daily steps and energy expenditure, physical activity duration in different intensity).
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Energy expenditure on SenseWear Activity Monitor
Periodo de tiempo: 5 days
|
The SenseWear software calculates energy expenditure based on a proprietary algorithm that incorporates subject height, weight, age, and sex which are entered prior to data analysis as well as the various measurements (two-axis accelerometry, galvanic skin response, heat flux, skin and near-body temperature).
|
5 days
|
|
Number of steps on SenseWear Activity Monitor
Periodo de tiempo: 5 days
|
The SenseWear software calculates number of steps based on a proprietary algorithm that incorporates subject height, weight, age, and sex which are entered prior to data analysis.
|
5 days
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
International Physical Activity Scale (IPAQ)
Periodo de tiempo: 10 minutes
|
27 item self-reported measure of physical activity for use with individual adult patients aged 15 to 69 years old.
The IPAQ can be used clinically and in population research that compares physical activity levels between populations internationally.
Duration (minutes) and frequency (days) of physical activity in the last 7 days is measured in domains of: Job-related, transportation, housework, house maintenance, caring for family, recreation, sport, leisure-time and time spent sitting.
Overall score calculated using responses to all questions (Score is obtained by multiplying duration and frequency for each question) and total MET-min/week score obtained.
|
10 minutes
|
|
Visual Analog Scale
Periodo de tiempo: 2 minutes
|
10 cm line anchored at both ends with words descriptive of the maximal and minimal extremes of the pain being measured.
Individuals mark their pain intensity on a line numbered 0-10.
|
2 minutes
|
|
Fatigue Severity Scale
Periodo de tiempo: 5 minutes
|
The 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders..
The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree.
The minimum score = 9 and maximum score possible = 63.
Higher the score = greater fatigue severity.
|
5 minutes
|
|
ACTIVLIM questionaire
Periodo de tiempo: 5 minutes
|
The ACTIVLIM questionnaire explores difficulties of performing daily activities that required the use of upper limbs or/and the use of lower limbs.
The adult patients and the parents of affected children fill in either the adult form or the child form of the questionnaire.
They are asked to provide their perceived difficulty in performing each activity using a three-level scale: impossible (0), difficult (1), easy (2).
Each activity must be completed without technical or human assistance.
|
5 minutes
|
|
Medical Outcomes Short-Form Health Survey
Periodo de tiempo: 10 minutes
|
The SF-36 is a generic patient-reported outcome measure aimed at quantifying health status, and is often used as a measure of health-related quality of life.
The SF-36 is a 36-item questionnaire that measures the physical and mental health constructs of health status.
These constructs are measured through 8 subscales.
The physical component (PCS) is made up of physical functioning (PF), role-physical (RP), bodily pain (BP), and general health (GH).
The Mental component (MCS) is made up of vitality (VT), social functioning (SF), role-emotional (RE), and mental health (ME).
Each of the 36 items is answered using a Likert-type scale and a 4-week recall period, with a total score of 0-100 possible.
A higher score indicates better health status.
|
10 minutes
|
|
Hand Held Dynamometry
Periodo de tiempo: 20 minutes
|
A quantitative and objective method for assessment of muscular strength using a portable hand held dynamometer.
"Break Test" option is used in the study.
"Break Test" where the tester applies a force to just overcome the strength of the person being tested, producing an eccentric muscular contraction and scored using force production in Newtons. 3 maximum voluntary isometric contractions are completed and scores summed.
|
20 minutes
|
|
Six Minutes Walk Test
Periodo de tiempo: 10 minutes
|
Assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
Walk of cover as far a distance as possible over 6 minute.
Assistive devices can be used but kept consistent from test to test.
Individual should be able to ambulate without physical assistance.
|
10 minutes
|
|
Timed Up and Go Test
Periodo de tiempo: 2 minutes
|
Assesses mobility, balance, walking ability, and fall risk.
The patient sits in the chair with his/her back against the chair back.
On the command "go", the patient rises from the chair, walks 3 meters at a comfortable and safe pace, turns, walks back to the chair and sits down.
Timing begins at the instruction "go" and stops when the patient is seated.
Patient must use the same assistive device each time he/she is tested to be able to compare scores.
3 trials are completed and scores summed.
|
2 minutes
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Fatma Ayvat, Msc, Hacettepe University
- Investigador principal: Muhammed Kılınç, Assoc Prof, Hacettepe University
- Director de estudio: Sibel Aksu Yıldırım, Prof, Hacettepe University
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
- Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903.
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available. Erratum In: Am J Respir Crit Care Med. 2016 May 15;193(10):1185.
- Price DD, Bush FM, Long S, Harkins SW. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain. 1994 Feb;56(2):217-226. doi: 10.1016/0304-3959(94)90097-3.
- McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil. 2002 Nov;81(11 Suppl):S108-20. doi: 10.1097/00002060-200211001-00012.
- McCrory MA, Kim HR, Wright NC, Lovelady CA, Aitkens S, Kilmer DD. Energy expenditure, physical activity, and body composition of ambulatory adults with hereditary neuromuscular disease. Am J Clin Nutr. 1998 Jun;67(6):1162-9. doi: 10.1093/ajcn/67.6.1162.
- Kilmer DD, Wright NC, Aitkens S. Impact of a home-based activity and dietary intervention in people with slowly progressive neuromuscular diseases. Arch Phys Med Rehabil. 2005 Nov;86(11):2150-6. doi: 10.1016/j.apmr.2005.07.288.
- Mulligan HF, Hale LA, Whitehead L, Baxter GD. Barriers to physical activity for people with long-term neurological conditions: a review study. Adapt Phys Activ Q. 2012 Jul;29(3):243-65. doi: 10.1123/apaq.29.3.243.
- Scheers T, Philippaerts R, Lefevre J. Variability in physical activity patterns as measured by the SenseWear Armband: how many days are needed? Eur J Appl Physiol. 2012 May;112(5):1653-62. doi: 10.1007/s00421-011-2131-9. Epub 2011 Aug 28.
- Saglam M, Arikan H, Savci S, Inal-Ince D, Bosnak-Guclu M, Karabulut E, Tokgozoglu L. International physical activity questionnaire: reliability and validity of the Turkish version. Percept Mot Skills. 2010 Aug;111(1):278-84. doi: 10.2466/06.08.PMS.111.4.278-284.
- Brinkmann JR. Comparison of a hand-held and fixed dynamometer in measuring strength of patients with neuromuscular disease. J Orthop Sports Phys Ther. 1994 Feb;19(2):100-4. doi: 10.2519/jospt.1994.19.2.100.
- Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, Karabudak R. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007 Mar;30(1):81-5. doi: 10.1097/MRR.0b013e3280146ec4.
- Vandervelde L, Van den Bergh PY, Goemans N, Thonnard JL. ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders. Neuromuscul Disord. 2007 Jun;17(6):459-69. doi: 10.1016/j.nmd.2007.02.013. Epub 2007 Apr 11.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de marzo de 2016
Finalización primaria (Actual)
1 de junio de 2017
Finalización del estudio (Actual)
1 de julio de 2017
Fechas de registro del estudio
Enviado por primera vez
15 de enero de 2017
Primero enviado que cumplió con los criterios de control de calidad
21 de enero de 2017
Publicado por primera vez (Estimar)
25 de enero de 2017
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
30 de julio de 2020
Última actualización enviada que cumplió con los criterios de control de calidad
29 de julio de 2020
Última verificación
1 de julio de 2020
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- GO 14/617
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .